365 related articles for article (PubMed ID: 15970352)
1. Oxidative stress and apoptosis in fetal rat liver induced by maternal cholestasis. Protective effect of ursodeoxycholic acid.
Perez MJ; Macias RI; Duran C; Monte MJ; Gonzalez-Buitrago JM; Marin JJ
J Hepatol; 2005 Aug; 43(2):324-32. PubMed ID: 15970352
[TBL] [Abstract][Full Text] [Related]
2. Maternal cholestasis induces placental oxidative stress and apoptosis. Protective effect of ursodeoxycholic acid.
Perez MJ; Macias RI; Marin JJ
Placenta; 2006 Jan; 27(1):34-41. PubMed ID: 16310035
[TBL] [Abstract][Full Text] [Related]
3. Multiple protective effects of melatonin against maternal cholestasis-induced oxidative stress and apoptosis in the rat fetal liver-placenta-maternal liver trio.
Perez MJ; Castaño B; Gonzalez-Buitrago JM; Marin JJ
J Pineal Res; 2007 Sep; 43(2):130-9. PubMed ID: 17645691
[TBL] [Abstract][Full Text] [Related]
4. Effect of maternal cholestasis and treatment with ursodeoxycholic acid on the expression of genes involved in the secretion of biliary lipids by the neonatal rat liver.
Macias RI; Jimenez S; Serrano MA; Monte MJ; Marin JJ
Life Sci; 2006 Aug; 79(10):1014-9. PubMed ID: 16764892
[TBL] [Abstract][Full Text] [Related]
5. Long-term effect of treating pregnant rats with ursodeoxycholic acid on the congenital impairment of bile secretion induced in the pups by maternal cholestasis.
Macias RI; Serrano MA; Monte MJ; Jimenez S; Hernandez B; Marin JJ
J Pharmacol Exp Ther; 2005 Feb; 312(2):751-8. PubMed ID: 15452192
[TBL] [Abstract][Full Text] [Related]
6. Effect of ursodeoxycholic acid on the impairment induced by maternal cholestasis in the rat placenta-maternal liver tandem excretory pathway.
Serrano MA; Macias RI; Vallejo M; Briz O; Bravo A; Pascual MJ; St-Pierre MV; Stieger B; Meier PJ; Marin JJ
J Pharmacol Exp Ther; 2003 May; 305(2):515-24. PubMed ID: 12606635
[TBL] [Abstract][Full Text] [Related]
7. Maternal ethanol consumption during pregnancy enhances bile acid-induced oxidative stress and apoptosis in fetal rat liver.
Perez MJ; Velasco E; Monte MJ; Gonzalez-Buitrago JM; Marin JJ
Toxicology; 2006 Aug; 225(2-3):183-94. PubMed ID: 16824660
[TBL] [Abstract][Full Text] [Related]
8. Role of vitamin C transporters and biliverdin reductase in the dual pro-oxidant and anti-oxidant effect of biliary compounds on the placental-fetal unit in cholestasis during pregnancy.
Perez MJ; Castaño B; Jimenez S; Serrano MA; Gonzalez-Buitrago JM; Marin JJ
Toxicol Appl Pharmacol; 2008 Oct; 232(2):327-36. PubMed ID: 18706437
[TBL] [Abstract][Full Text] [Related]
9. Fetal origin of adverse pregnancy outcome: the water disinfectant by-product chloroacetonitrile induces oxidative stress and apoptosis in mouse fetal brain.
Ahmed AE; Jacob S; Campbell GA; Harirah HM; Perez-Polo JR; M Johnson K
Brain Res Dev Brain Res; 2005 Sep; 159(1):1-11. PubMed ID: 16054234
[TBL] [Abstract][Full Text] [Related]
10. Antioxidant mechanism of hepatoprotection by ursodeoxycholic acid in experimental alcoholic steatohepatitis.
Lukivskaya O; Zavodnik L; Knas M; Buko V
Adv Med Sci; 2006; 51():54-9. PubMed ID: 17357278
[TBL] [Abstract][Full Text] [Related]
11. New therapeutical indications of ursodeoxycholic acid.
Copaci I; Micu L; Iliescu L; Voiculescu M
Rom J Gastroenterol; 2005 Sep; 14(3):259-66. PubMed ID: 16200237
[TBL] [Abstract][Full Text] [Related]
12. Reversible impairment of neonatal hepatobiliary function by maternal cholestasis.
Monte MJ; Morales AI; Arevalo M; Alvaro I; Macias RI; Marin JJ
Hepatology; 1996 May; 23(5):1208-17. PubMed ID: 8621155
[TBL] [Abstract][Full Text] [Related]
13. Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers.
Mazzella G; Rizzo N; Azzaroli F; Simoni P; Bovicelli L; Miracolo A; Simonazzi G; Colecchia A; Nigro G; Mwangemi C; Festi D; Roda E
Hepatology; 2001 Mar; 33(3):504-8. PubMed ID: 11230728
[TBL] [Abstract][Full Text] [Related]
14. Ursodeoxycholic acid protects against secondary biliary cirrhosis in rats by preventing mitochondrial oxidative stress.
Serviddio G; Pereda J; Pallardó FV; Carretero J; Borras C; Cutrin J; Vendemiale G; Poli G; Viña J; Sastre J
Hepatology; 2004 Mar; 39(3):711-20. PubMed ID: 14999689
[TBL] [Abstract][Full Text] [Related]
15. Effect of maternal cholestasis on bile acid transfer across the rat placenta-maternal liver tandem.
Macias RI; Pascual MJ; Bravo A; Alcalde MP; Larena MG; St-Pierre MV; Serrano MA; Marin JJ
Hepatology; 2000 Apr; 31(4):975-83. PubMed ID: 10733555
[TBL] [Abstract][Full Text] [Related]
16. Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications.
Roma MG; Toledo FD; Boaglio AC; Basiglio CL; Crocenzi FA; Sánchez Pozzi EJ
Clin Sci (Lond); 2011 Dec; 121(12):523-44. PubMed ID: 21854363
[TBL] [Abstract][Full Text] [Related]
17. Progesterone metabolites and bile acids in serum of patients with intrahepatic cholestasis of pregnancy: effect of ursodeoxycholic acid therapy.
Meng LJ; Reyes H; Axelson M; Palma J; Hernandez I; Ribalta J; Sjövall J
Hepatology; 1997 Dec; 26(6):1573-9. PubMed ID: 9398000
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of ursodeoxycholic acid on liver mitochondrial function in rats with alloxan-induced diabetes: link with oxidative stress.
Lukivskaya O; Patsenker E; Buko VU
Life Sci; 2007 Jun; 80(26):2397-402. PubMed ID: 17512017
[TBL] [Abstract][Full Text] [Related]
19. Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha.
Alpini G; Baiocchi L; Glaser S; Ueno Y; Marzioni M; Francis H; Phinizy JL; Angelico M; Lesage G
Hepatology; 2002 May; 35(5):1041-52. PubMed ID: 11981754
[TBL] [Abstract][Full Text] [Related]
20. Endogenous opioids modulate hepatocyte apoptosis in a rat model of chronic cholestasis: the role of oxidative stress.
Payabvash S; Kiumehr S; Nezami BG; Zandieh A; Anvari P; Tavangar SM; Dehpour AR
Liver Int; 2007 May; 27(4):538-47. PubMed ID: 17403194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
